Science Corp's Vision-Restoring Brain Chip Receives EU Regulatory Approval
Science Corporation has received European Union approval for its vision-restoring chip, marking a significant regulatory milestone for the neurotechnology company. The device is designed to restore sight to individuals with severe visual impairment. CEO Max Hodak has emphasized the need for commercial scale, stating the sector requires a company generating $100 million annually in revenue. The approval opens the door for Science Corp to potentially market and deploy its technology across EU member states. This development positions the company as a notable contender in the growing neurotechnology and medical device space.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in